Home › T-Cell Lymphoma › Connecticut
T-Cell Lymphoma clinical trials in Connecticut
5 studies for T-Cell Lymphoma are looking for participants at sites in Connecticut.
Cities in Connecticut
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
- Yale University, New Haven
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06561048A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL
- Yale Cancer Center, New Haven
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06854653Pembrolizumab and Brentuximab Vedotin in Subjects With Relapsed/Refractory T-cell Lymphoma
- Yale Smilow Cancer Hospital, New Haven
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jun 11, 2026 · NCT05313243A Registry for People With T-cell Lymphoma
- Yale University (Data Collection Only), New Haven
RecruitingObservational study
All ages · All sexes · Updated May 20, 2026 · NCT05978141Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell Lymphoma
- Yale Cancer Center, Clinical Trials Office, New Haven
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 14, 2026 · NCT05996185From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.